Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to ...
The history of therapy is difficult to quantify in that, for as long as human beings have walked the Earth, they have shared ...
Plant-based medicine advocates haven’t given up their efforts to see that therapeutic method take root. Question 4, defeated ...
Ibogaine — a psychoactive plant derivative — has attracted attention for its anti-addictive and anti-depressant properties. But ibogaine is a finite resource, extracted from plants native to Africa ...
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation (RPDD) to Arbor Biotechnologies' gene editing therapeutic, ABO-101, to treat ...
A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...
In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan ...
Favorable bleeding outcomes related to abelacimab have positioned the medication as a potential game changer in the treatment of atrial fibrillation.
Readers worry that fraud may tarnish the field and slow the race for a cure. Also: Charles Blow’s farewell; treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback